Gene regulatory network inference based on a nonhomogeneous dynamic Bayesian network model with an improved Markov
Jiayao Zhang1, Chunling Hu2, Qianqian Zhang1
1College of Artificial Intelligence and Big Data, Hefei University, Hefei, 230031, China.
This study introduces a novel gene regulatory network model (FC-DBN) that improves accuracy and convergence by using Manhattan distance and particle filtering for non-stationary gene expression data analysis.
Area of Science:
- Computational Biology
- Systems Biology
- Bioinformatics
Background:
- Dynamic Bayesian Networks (DBNs) struggle with non-stationary gene expression data.
- Existing models face challenges in network reconstruction accuracy and model convergence.
Purpose of the Study:
- To enhance DBNs for non-stationary gene expression data.
- To improve network reconstruction accuracy and model convergence speed.
Main Methods:
- Developed an MD-birth move using Manhattan distance for multi-change point processes.
- Implemented a node-dependent particle filtering-based Markov chain Monte Carlo sampling method.
- Proposed the FInal Convergence Dynamic Bayesian Network (FC-DBN) model.
Main Results:
- The MD-birth move increases the rationality of the multi-change point process.
- Node-dependent particle filtering improves sampling efficiency for gene regulatory network reconstruction.
- FC-DBN demonstrates superior network reconstruction accuracy and faster convergence compared to existing models on Saccharomyces cerevisiae and RAF datasets.
Conclusions:
- The proposed FC-DBN model effectively addresses limitations in modeling non-stationary gene expression data.
- The novel methods enhance the performance of dynamic Bayesian networks for gene regulatory network inference.
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
On...
Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
Mutation, Gene Flow, and Genetic Drift
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.


